• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢体恶性黑色素瘤中使用细胞抑制剂进行区域热灌注(作者译)

[Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].

作者信息

Ghussen F, Nagel K, Groth W

出版信息

Dtsch Med Wochenschr. 1981 Nov 27;106(48):1612-5. doi: 10.1055/s-2008-1070564.

DOI:10.1055/s-2008-1070564
PMID:7308000
Abstract

From December 1978 to February 1981 91 regional hyperthermic perfusions with melphalan (1.0 or 1.5 mg/kg body weight) were performed in 87 patients with malignant melanoma of the extremities. During a one-hour perfusion with whole blood at an intramuscular temperature of 42 degrees C the flow rate was 264 +/- 62 ml/min in the upper and 495 +/- 42 ml/min in the lower limb. Apart from one intima dissection there were no serious intraoperative complications. Postoperatively one female patient died on the 19th day from acute right heart failure with severe bone marrow suppression. In six patients intransigent metastases appeared after an average of six months. One patient developed lung metastases 7 months postoperatively from which he died. Seventy-nine patients remained free of tumour during the observation period.

摘要

1978年12月至1981年2月,对87例四肢恶性黑色素瘤患者进行了91次美法仑(1.0或1.5mg/kg体重)区域热灌注治疗。在肌肉温度为42℃的全血灌注1小时过程中,上肢血流量为264±62ml/min,下肢为495±42ml/min。除1例内膜剥离外,无严重术中并发症。术后1例女性患者于第19天死于急性右心衰竭伴严重骨髓抑制。6例患者平均6个月后出现顽固性转移。1例患者术后7个月发生肺转移并死亡。79例患者在观察期内无肿瘤复发。

相似文献

1
[Regional hyperthermic perfusion with cytostatic agents in malignant melanoma of the extremities (author's transl)].肢体恶性黑色素瘤中使用细胞抑制剂进行区域热灌注(作者译)
Dtsch Med Wochenschr. 1981 Nov 27;106(48):1612-5. doi: 10.1055/s-2008-1070564.
2
[Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].肢体区域灌注——81例恶性黑色素瘤患者的经验(作者译)
Z Hautkr. 1981 Jul 15;56(14):911-20.
3
[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].[美法仑和肿瘤坏死因子在恶性黑色素瘤中的肢体隔离热灌注治疗]
Dtsch Med Wochenschr. 1997 Feb 14;122(7):177-81. doi: 10.1055/s-2008-1047593.
4
Hyperthermic perfusion of recurrent malignant melanoma on the extremities.肢体复发性恶性黑色素瘤的热灌注治疗
Acta Chir Scand. 1980;146(5):313-8.
5
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.美法仑与肿瘤坏死因子-α 进行离体肢体灌注后的局部毒性与单独使用美法仑后的毒性比较。
Eur J Surg Oncol. 2001 Jun;27(4):390-5. doi: 10.1053/ejso.2001.1124.
6
Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.黑色素瘤患者在美法仑和放线菌素D隔离肢体灌注后急性局部毒性的预测因素。
Ann Surg Oncol. 2009 May;16(5):1184-92. doi: 10.1245/s10434-009-0323-x. Epub 2009 Feb 18.
7
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.用美法仑重复进行肢体隔离灌注治疗肢体复发性黑色素瘤。
J Am Coll Surg. 1996 Jun;182(6):467-72.
8
Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan.采用肿瘤坏死因子-α(TNF-α)、美法仑和干扰素-γ(IFN-γ)隔离灌注治疗皮肤黑色素瘤的远处转移。米兰国立癌症研究所的剂量探索经验。
Melanoma Res. 1994 Mar;4 Suppl 1:35-8.
9
Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020.美法仑单独热灌注隔离肢体与美法仑加肿瘤坏死因子的随机多中心试验:美国外科医师学会肿瘤学组Z0020试验
J Clin Oncol. 2006 Sep 1;24(25):4196-201. doi: 10.1200/JCO.2005.05.5152.
10
[Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
Ann Dermatol Venereol. 1988;115(5):573-85.

引用本文的文献

1
[Stroma-free hemoglobin solution and perfusion of isolated extremities].
Langenbecks Arch Chir. 1984;362(2):119-30. doi: 10.1007/BF01254186.